Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-268P is a human pseudogene related to the U6 small nuclear RNA (snRNA) gene family. The U6 snRNA is a major component of the spliceosome, which catalyzes the removal of introns from pre-mRNA[1][3]. However, as a pseudogene, RNU6-268P does not encode a functional RNA or protein. Pseudogenes like RNU6-268P are generally considered non-functional remnants of gene duplication or retrotransposition events, although the broader family of pseudogenes can occasionally be transcribed and exert regulatory effects, such as acting as miRNA decoys or ensuring post-transcriptional regulation of their parental genes[2]. There is currently no evidence that RNU6-268P itself participates in any known biological pathway, disease mechanism, or functions as a drug target[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 268, pseudogene (RNU6-268P).